Cargando…

Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies

INTRODUCTION: Digestive system pan-cancer is one of the lethal malignant tumors, which have the propensity for poor prognosis and difficult treatment. Endoplasmic reticulum (ER) stress has served as a pivotal role in the progression of the tumor, while the implication of ER stress on digestive syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Sheng, Yu, Yuanquan, Xu, Liyi, Pan, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868864/
https://www.ncbi.nlm.nih.gov/pubmed/36698399
http://dx.doi.org/10.3389/fonc.2022.1072576
_version_ 1784876640123224064
author Yao, Sheng
Yu, Yuanquan
Xu, Liyi
Pan, Xiang
author_facet Yao, Sheng
Yu, Yuanquan
Xu, Liyi
Pan, Xiang
author_sort Yao, Sheng
collection PubMed
description INTRODUCTION: Digestive system pan-cancer is one of the lethal malignant tumors, which have the propensity for poor prognosis and difficult treatment. Endoplasmic reticulum (ER) stress has served as a pivotal role in the progression of the tumor, while the implication of ER stress on digestive system pan-cancers still needs elucidation, especially from the perspective of clinical outcome and that of genomic features. METHODS: First, Among the ER STRESS factors from the REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR (113 genes) and HALLMARK_UNFOLDED_PROTEIN_RESPONSE (92 genes) terms, 153 ER STRESS regulators were identified after removing replicates. The somatic mutation data and copy number variation data of gastrointestinal pan-cancer were downloaded from The Cancer Genome Atlas (TCGA) database. Then, we explored the clinical outcome and genetic mutation of ER stress-related differentially expressed genes (DEGs) by multiple bioinformatics analysis. Subsequently, we analyzed the Spearman correlation between the drug sensitivity of 179 gastrointestinal anticancer drugs and the transcriptional expression of 153 ER stress factors in 769 cancer cell lines of the GDSC2 cohort. Next, ssGSEA method was used to quantify the immune cell infiltration scores in the tumor microenvironment, and Spearman correlation was used to calculate the correlation between ER stress scores and immune cell infiltration. Finally, we analyzed the cellular origin of ER stress factor dysregulation. RESULTS: We analyzed the genomic changes and clinical outcomes of ER stress factors in different tumors of gastrointestinal pan-cancer. Endoplasmic reticulum stress factor (ER) in digestive tract tumors showed high SNV mutation frequency, less methylation dysregulation and was associated with multiple oncogenic pathways. Endoplasmic reticulum stress factor (ER) is a risk factor for many cancers, but the effect on overall survival in rectal adenocarcinoma is opposite to that in other gastrointestinal tumors. And ER stress factors are highly correlated with drugs that target important pathways. DISCUSSION: Based on the clinical prognosis and genomic analysis of ER stress-related factors in patients with gastrointestinal pan-cancer, this study provides a new direction for further research on gastrointestinal pan-cancer.
format Online
Article
Text
id pubmed-9868864
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98688642023-01-24 Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies Yao, Sheng Yu, Yuanquan Xu, Liyi Pan, Xiang Front Oncol Oncology INTRODUCTION: Digestive system pan-cancer is one of the lethal malignant tumors, which have the propensity for poor prognosis and difficult treatment. Endoplasmic reticulum (ER) stress has served as a pivotal role in the progression of the tumor, while the implication of ER stress on digestive system pan-cancers still needs elucidation, especially from the perspective of clinical outcome and that of genomic features. METHODS: First, Among the ER STRESS factors from the REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR (113 genes) and HALLMARK_UNFOLDED_PROTEIN_RESPONSE (92 genes) terms, 153 ER STRESS regulators were identified after removing replicates. The somatic mutation data and copy number variation data of gastrointestinal pan-cancer were downloaded from The Cancer Genome Atlas (TCGA) database. Then, we explored the clinical outcome and genetic mutation of ER stress-related differentially expressed genes (DEGs) by multiple bioinformatics analysis. Subsequently, we analyzed the Spearman correlation between the drug sensitivity of 179 gastrointestinal anticancer drugs and the transcriptional expression of 153 ER stress factors in 769 cancer cell lines of the GDSC2 cohort. Next, ssGSEA method was used to quantify the immune cell infiltration scores in the tumor microenvironment, and Spearman correlation was used to calculate the correlation between ER stress scores and immune cell infiltration. Finally, we analyzed the cellular origin of ER stress factor dysregulation. RESULTS: We analyzed the genomic changes and clinical outcomes of ER stress factors in different tumors of gastrointestinal pan-cancer. Endoplasmic reticulum stress factor (ER) in digestive tract tumors showed high SNV mutation frequency, less methylation dysregulation and was associated with multiple oncogenic pathways. Endoplasmic reticulum stress factor (ER) is a risk factor for many cancers, but the effect on overall survival in rectal adenocarcinoma is opposite to that in other gastrointestinal tumors. And ER stress factors are highly correlated with drugs that target important pathways. DISCUSSION: Based on the clinical prognosis and genomic analysis of ER stress-related factors in patients with gastrointestinal pan-cancer, this study provides a new direction for further research on gastrointestinal pan-cancer. Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9868864/ /pubmed/36698399 http://dx.doi.org/10.3389/fonc.2022.1072576 Text en Copyright © 2023 Yao, Yu, Xu and Pan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yao, Sheng
Yu, Yuanquan
Xu, Liyi
Pan, Xiang
Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
title Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
title_full Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
title_fullStr Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
title_full_unstemmed Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
title_short Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
title_sort genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868864/
https://www.ncbi.nlm.nih.gov/pubmed/36698399
http://dx.doi.org/10.3389/fonc.2022.1072576
work_keys_str_mv AT yaosheng genomicandclinicalfeaturesofendoplasmicreticulumstressfactorindigestivesystempancancerstudies
AT yuyuanquan genomicandclinicalfeaturesofendoplasmicreticulumstressfactorindigestivesystempancancerstudies
AT xuliyi genomicandclinicalfeaturesofendoplasmicreticulumstressfactorindigestivesystempancancerstudies
AT panxiang genomicandclinicalfeaturesofendoplasmicreticulumstressfactorindigestivesystempancancerstudies